A Surprising Setback: FDA's Unexpected Rejection Jolts Disc Medicine and Patient Community In a significant blow to Disc Medicine and the patient community it serves, the U.S. Food and Drug Administration (FDA) has officially rejected the company's application for bitopertin, a novel drug
With his extensive background in medical technology and a deep focus on driving innovation, Faisal Zain has become a leading voice in the application of value-based care to solve some of healthcare’s most persistent challenges. Today, we'll delve into his insights on transforming care for c
Introduction: Assessing a New Oral Therapy for Achondroplasia For families navigating the complexities of achondroplasia, the prospect of replacing daily or weekly injections with a simple pill represents a profound shift in the treatment paradigm. This review evaluates the potential of
In the complex landscape of corporate benefits, employers have long navigated the difficult choice between costly, often confusing Preferred Provider Organization (PPO) plans and more restrictive Health Maintenance Organizations (HMOs). This persistent challenge has fueled a growing demand for
We are joined by Dr. Lauren Waterman, a consultant psychiatrist specializing in the intricate science of insomnia. In our conversation, we will explore the often-misunderstood differences between insomnia and sleep deprivation, the psychological traps that turn normal nighttime awakenings into
The American healthcare system is in the midst of a profound transformation, moving decisively away from a fee-for-service model that rewards the sheer volume of procedures toward a value-based framework that prioritizes quality outcomes and cost-efficiency. For rehabilitation professionals,
